A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945

NCT02715570 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Aspergillosis

Interventions

DRUG: PC945 - single doses
DRUG: Placebo - single doses
DRUG: PC945 - repeat doses
DRUG: Placebo - repeat doses

Sponsor

Pulmocide Ltd